Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the popular weight-loss drugs ...
Medicare Medicare is federal health insurance for people 65 or older, and some people under 65 with certain disabilities or conditions. A federal agency called the Centers for Medicare & Medicaid Services runs Medicare. Because it’s a federal program, Medicare has set standards for costs and coverage. This means a person’s Medicare coverage will be the same no matter what state they live in.
Medicare has delayed its BALANCE program for weight-loss drugs like Wegovy. Discover the new 'bridge program' that will offer coverage for a $50 copay starting in 2026.
Medicare’s proposed pilot to cover GLP-1 drugs like Wegovy and Zepbound has been delayed. President Donald Trump once promised lower prices on blockbuster weight-loss drugs in exchange for expanding ...
The Trump administration is delaying a pilot program where Medicare would cover the costs of GLP-1 weight-loss drugs, such as Wegovy and Zepbound, after major insurers declined to participate.
The Motley Fool: Will Medicare Cover Ozempic or Wegovy in 2026? What Retirees Need to Know About GLP-1 Coverage
Medicare currently covers GLP-1s to treat conditions like Type 2 diabetes. It will begin covering the drug for weight loss with prior authorization beginning in July 2026. It'll be up to Part D plan ...
Will Medicare Cover Ozempic or Wegovy in 2026? What Retirees Need to Know About GLP-1 Coverage
Medicare will begin covering weight loss drugs in 2026 for the first time under a pricing agreement announced by the White House, according to a Nov. 6 press release. The agreements with Eli Lilly and ...